chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Left arm pain; Chills; Body aches; Headache; Feeling feverish; Tired; Dose received: 3; This is a spontaneous report from a contactable reporter (consumer or other non HCP). The reporter is the patient.  A 45-year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 08Dec2021 (Lot number: FG3527) at the age of 45 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing), notes: High blood pressure. Concomitant medication included: AMLODIPINE. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot number: EL3247; Anatomical site: unspecified; Route of administration: unspecified), administration date: 22Feb2021, when the patient was 44 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE; Lot number: EL3247; Anatomical site: left arm; Route of administration: intramuscular), administration date: 15Mar2021, when the patient was 44 years old, for COVID-19 immunisation. The following information was reported: IMMUNISATION (non-serious) with onset 08Dec2021, outcome "unknown", described as "Dose received: 3"; PAIN IN EXTREMITY (non-serious) with onset 08Dec2021 at 22:00, outcome "not recovered", described as "Left arm pain"; CHILLS (non-serious) with onset 08Dec2021 at 22:00, outcome "not recovered", described as "Chills"; PAIN (non-serious) with onset 08Dec2021 at 22:00, outcome "not recovered", described as "Body aches"; HEADACHE (non-serious) with onset 08Dec2021 at 22:00, outcome "not recovered", described as "Headache"; PYREXIA (non-serious) with onset 08Dec2021 at 22:00, outcome "not recovered", described as "Feeling feverish"; FATIGUE (non-serious) with onset 08Dec2021 at 22:00, outcome "not recovered", described as "Tired". Therapeutic measures were taken as a result of pain in extremity, chills, pain, headache, pyrexia and fatigue.  Additional Information: The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment included Ibuprofen for pain in extremity, chills, pain, headache, pyrexia and fatigue.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling cold, Feeling hot, Flushing, Moaning, Pain
Clinical narrative: Freezing cold; Everything hurt; He was moaning/whimpering; His entire body was very hot; His face flushed; This is a spontaneous report received from a contactable reporter (consumer or other non-HCP). The reporter is the parent.   A 12 year-old male patient received bnt162b2 (BNT162B2), administered in right arm, administration date 09Dec2021 at 15:30 (Lot number: FE3590)at the age of 12 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "Attention deficit-hyperactivity disorder" (unspecified if ongoing), notes: ADHD and medication for that. Concomitant medications included: METHYLPHENIDATE. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: FK5127, Anatomical location: Right arm, Administration Time: 12:00), administration date: 04Nov2021, when the patient was 11 years old, for COVID-19 immunisation.  The following information was reported: FEELING COLD (non-serious) with onset 10Dec2021 at 00:30, outcome "not recovered", described as "Freezing cold"; PAIN (non-serious) with onset 10Dec2021 at 00:30, outcome "not recovered", described as "Everything hurt"; MOANING (non-serious) with onset 10Dec2021 at 00:30, outcome "not recovered", described as "He was moaning/whimpering"; FEELING HOT (non-serious) with onset 10Dec2021 at 00:30, outcome "not recovered", described as "His entire body was very hot"; FLUSHING (non-serious) with onset 10Dec2021 at 00:30, outcome "not recovered", described as "His face flushed". Therapeutic measures were taken as a result of feeling cold, pain, moaning, feeling hot and flushing.   Additional Information: The patient had no known allergies. The patient did not receive other vaccines within four weeks prior to COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Around 00:30, the patient came into the parent's bedroom claiming to be freezing cold and by 12:30 symptoms had not improved. He had taken three baths to warm up, been given Tylenol, had not eaten anything yet that morning (reported as this morning) and was sleeping (reported as now sleeping). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Treatment included Tylenol for feeling cold, pain, moaning, feeling hot and flushing.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Immunisation, Malaise, Rhinorrhoea
Clinical narrative: Runny nose; Fatigue; Headache; General malaise; Dose received 3; This is a spontaneous report received from a contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 48-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm, administration date 09Dec2021 at 12:30 (Lot number: 1620) at the age of 48 years as dose 3 (booster), single for COVID-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: 6955, Anatomical site: Right arm, Administration time: 13:30), administration date: 18Mar2021, when the patient was 47 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot number: 6955, Anatomical site: Right arm, Administration time: 11:00), administration date: 08Apr2021, when the patient was 47 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 09Dec2021 at 12:30, outcome "unknown", described as "Dose received 3"; RHINORRHOEA (non-serious) with onset 10Dec2021 at 07:00, outcome "not recovered", described as "Runny nose"; FATIGUE (non-serious) with onset 10Dec2021 at 07:00, outcome "not recovered", described as "Fatigue"; HEADACHE (non-serious) with onset 10Dec2021 at 07:00, outcome "not recovered", described as "Headache"; MALAISE (non-serious) with onset 10Dec2021 at 07:00, outcome "not recovered", described as "General malaise". Therapeutic measures were not taken as a result of rhinorrhoea, fatigue, headache and malaise.  Additional information: The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Hypoaesthesia, Immunisation
Clinical narrative: Chest tightness; Numbness of the toes 3 plus days after taking the booster shot; Dose received 3; This is a spontaneous report received from a contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm, administration date 06Dec2021 at 10:30 (Lot number: 33130BA) at the age of 27 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19?: Yes. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot number: EN6206; Anatomical site: Left arm; Administration time: 12:00), administration date: 15Mar2021, when the patient was 26 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE; Lot number: EW0150; Anatomical site: Left arm; Administration time: 12:00), administration date: 11Apr2021, when the patient was 26 years old, for COVID-19 immunisation. The following information was reported: IMMUNISATION (non-serious) with onset 06Dec2021 at 10:30, outcome "unknown", described as "Dose received 3"; CHEST DISCOMFORT (non-serious) with onset 07Dec2021 at 12:00, outcome "not recovered", described as "Chest tightness"; HYPOAESTHESIA (non-serious) with onset 07Dec2021 at 12:00, outcome "not recovered", described as "Numbness of the toes 3 plus days after taking the booster shot". Therapeutic measures were not taken as a result of chest discomfort and hypoaesthesia.  Additional Information: The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Immunisation, Lymphadenopathy, Nausea, Vaccination site pain
Clinical narrative: On Saturday morning which was day 2 after the shot, woke up with a swollen lymph node under my arm on the injection site side; Dose received: 3; Injection site pain; Headache; Nausea; This is a spontaneous report from a contactable reporter (consumer or other non HCP). The reporter is the patient.   A 45-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm, administration date 09Dec2021 at 14:15 (Lot number: FJ1620) at the age of 45 years as dose 3 (booster), single for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 2, SINGLE, Lot number: ER8735, Anatomical location: Left arm, Administration time: 15:30), administration date: 27Apr2021, when the patient was 44 years old, and Bnt162b2 (DOSE 1, SINGLE, Lot number: EW0151, Anatomical location: Left arm, Administration time: 12:00), administration date: 06Apr2021, when the patient was 44 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 09Dec2021 at 14:15, outcome "unknown", described as "Dose received: 3"; VACCINATION SITE PAIN (non-serious) with onset an unknown date in Dec2021, outcome "not recovered", described as "Injection site pain"; HEADACHE (non-serious) with onset an unknown date in Dec2021, outcome "not recovered", described as "Headache"; NAUSEA (non-serious) with onset an unknown date in Dec2021, outcome "not recovered", described as "Nausea"; LYMPHADENOPATHY (non-serious) with onset 11Dec2021 at 09:00, outcome "not recovered", described as "On Saturday morning which was day 2 after the shot, woke up with a swollen lymph node under my arm on the injection site side". Therapeutic measures were not taken as a result of vaccination site pain, headache, nausea and lymphadenopathy.  Additional Information: The patient had no known allergies. The patient did not receive other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Eye pain
Clinical narrative: Eye pain in right eye; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 38 year-old male patient received bnt162b2 (BNT162B2), administration date 08Dec2021 12:00 (Batch/Lot number: unknown) at the age of 38 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Sulfonamide allergy" (unspecified if ongoing). Concomitant medication(s) included: ZYRTEC [CETIRIZINE HYDROCHLORIDE]. The following information was reported: EYE PAIN (non-serious) with onset 11Dec2021 12:00, outcome "not recovered", described as "Eye pain in right eye". The event "eye pain in right eye" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of eye pain.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient had not been diagnosed with COVID-19 and since the vaccination the patient had not been tested for COVID-19.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Discomfort, Hangover, Headache, Illness
Clinical narrative: like a really bad hangover; really ill; My head hurt; nausea; didn't want to eat; even sitting up was difficult; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HANGOVER (non-serious), outcome "unknown", described as "like a really bad hangover"; ILLNESS (non-serious), outcome "unknown", described as "really ill"; HEADACHE (non-serious), outcome "unknown", described as "My head hurt"; NAUSEA (non-serious), outcome "unknown", described as "nausea"; DECREASED APPETITE (non-serious), outcome "unknown", described as "didn't want to eat"; DISCOMFORT (non-serious), outcome "unknown", described as "even sitting up was difficult". Additional information: It was reported that "I didn't get sick until 6 days after I was vaccinated. I had a delayed reaction. It was like a really bad hangover, instead of lasting a day it lasted for 6 days. I was really ill. My head hurt, nausea, didn't want to eat, even sitting up was difficult, only thing that helped was laying down 18 hours a day in bed. Now I'm 8 days out, day 7 better, today is day 8 not 100% but so much better than I was. I was contemplating the ER that's how bad it was. My head, body, nausea, overall sick feeling. No chills, or muscle or joint pain.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: like a really bad hangover; really ill; My head hurt; nausea; didn't want to eat; even sitting up was difficult; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HANGOVER (non-serious), outcome "unknown", described as "like a really bad hangover"; ILLNESS (non-serious), outcome "unknown", described as "really ill"; HEADACHE (non-serious), outcome "unknown", described as "My head hurt"; NAUSEA (non-serious), outcome "unknown", described as "nausea"; DECREASED APPETITE (non-serious), outcome "unknown", described as "didn't want to eat"; DISCOMFORT (non-serious), outcome "unknown", described as "even sitting up was difficult". Additional information: It was reported that "I didn't get sick until 6 days after I was vaccinated. I had a delayed reaction. It was like a really bad hangover, instead of lasting a day it lasted for 6 days. I was really ill. My head hurt, nausea, didn't want to eat, even sitting up was difficult, only thing that helped was laying down 18 hours a day in bed. Now I'm 8 days out, day 7 better, today is day 8 not 100% but so much better than I was. I was contemplating the ER that's how bad it was. My head, body, nausea, overall sick feeling. No chills, or muscle or joint pain.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "Pain at the injection site".   Additional information: Caller, 72 y/o male consumer, stated, "I got my first shot (Pfizer Covid-19 Vaccine) at the (Facility name withheld) yesterday, 03Mar2021. Caller stated his second vaccination is scheduled on 24Mar2021. Caller stated he has two appointments scheduled on the 24th and need help rescheduling. Caller stated the only contact information he has is a website on the back of the vaccination card that was given to him after receiving his vaccination. However, caller stated he did not have a computer. Caller asked, "how long is your arm supposed to stay sore?" Caller confirmed that he was experiencing pain at the injection, above and beneath the site.  No follow-up attempts are possible; information about lot/batch number cannot been obtained. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Gastrointestinal disorder, Gastrointestinal inflammation, Gastrointestinal motility disorder
Clinical narrative: diarrhea; slowing of my bowels; loss of appetite; a lot of inflammation, inflamed intestinal tissue; GI Intestinal trouble; stoma is inflamed and it is like a volcano; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "colitis" (unspecified if ongoing); "ileostomy" (unspecified if ongoing), notes: Has had for 40 some years. There were no concomitant medications. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea"; GASTROINTESTINAL MOTILITY DISORDER (non-serious), outcome "unknown", described as "slowing of my bowels"; DECREASED APPETITE (non-serious), outcome "unknown", described as "loss of appetite"; GASTROINTESTINAL INFLAMMATION (non-serious), outcome "unknown", described as "a lot of inflammation, inflamed intestinal tissue"; GASTROINTESTINAL DISORDER (non-serious), outcome "unknown", described as "GI Intestinal trouble"; STOMA SITE INFLAMMATION (non-serious), outcome "unknown", described as "stoma is inflamed and it is like a volcano".  Additional information: She received her first Pfizer shot 1 week ago on Wednesday and that by Friday and last night she changed her appliance and noticed a lot of inflammation, inflamed intestinal tissue. She was not sure if the vaccine had caused some GI intestinal trouble. She wanted to know if inflammation in the intestinal area was a side effect. She was concerned that her stoma was inflamed and it was like a volcano. She just changed it yesterday and had side effects starting on Friday with her stomach. She doesn't know if she could get second shot if that would inflame it even worse in terms of a blockage or something. She has had this a lot of years and normally, she knew what she needed to do. This was different.   No follow up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Stoma site inflammation
Clinical narrative: diarrhea; slowing of my bowels; loss of appetite; a lot of inflammation, inflamed intestinal tissue; GI Intestinal trouble; stoma is inflamed and it is like a volcano; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "colitis" (unspecified if ongoing); "ileostomy" (unspecified if ongoing), notes: Has had for 40 some years. There were no concomitant medications. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea"; GASTROINTESTINAL MOTILITY DISORDER (non-serious), outcome "unknown", described as "slowing of my bowels"; DECREASED APPETITE (non-serious), outcome "unknown", described as "loss of appetite"; GASTROINTESTINAL INFLAMMATION (non-serious), outcome "unknown", described as "a lot of inflammation, inflamed intestinal tissue"; GASTROINTESTINAL DISORDER (non-serious), outcome "unknown", described as "GI Intestinal trouble"; STOMA SITE INFLAMMATION (non-serious), outcome "unknown", described as "stoma is inflamed and it is like a volcano".  Additional information: She received her first Pfizer shot 1 week ago on Wednesday and that by Friday and last night she changed her appliance and noticed a lot of inflammation, inflamed intestinal tissue. She was not sure if the vaccine had caused some GI intestinal trouble. She wanted to know if inflammation in the intestinal area was a side effect. She was concerned that her stoma was inflamed and it was like a volcano. She just changed it yesterday and had side effects starting on Friday with her stomach. She doesn't know if she could get second shot if that would inflame it even worse in terms of a blockage or something. She has had this a lot of years and normally, she knew what she needed to do. This was different.   No follow up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: Sinus infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 73 year-old male patient received bnt162b2 (BNT162B2), administration date Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SINUSITIS (non-serious), outcome "unknown", described as "Sinus infection".  Additional information: Patient had the first dose of Pfizer COVID vaccine last week and now patient was getting a sinus infection. Is it okay for patient to take an antibiotic, amoxicillin/clav.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Vomiting
Clinical narrative: She states she has had worse than chills; very tired; has thrown up twice and now has a headache; has thrown up twice and now has a headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHILLS (non-serious), outcome "unknown", described as "She states she has had worse than chills"; FATIGUE (non-serious), outcome "unknown", described as "very tired"; HEADACHE (non-serious), VOMITING (non-serious), outcome "unknown" and all described as "has thrown up twice and now has a headache".  Additional Information: Patient would like to know how long her symptoms could last. RA: E-transmitting AE due to long hold times, patient does not wish to stay on hold. Patient received the 1st dose of the Pfizer covid vaccine yesterday at 17:00 pm. She states she has had worse than chills, very tired, has thrown up twice and now has a headache. (2nd AE logged on different interaction: 00143571).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: arm sore; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 24Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered" (2021), described as "arm sore"; HEADACHE (non-serious), outcome "not recovered", described as "headache". Therapeutic measures were taken as a result of headache.  Additional information: Headache that was unrelieved by Extra Strength Tylenol and was asking if she can take Advil. Patient dose 2 was scheduled for 17March2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia
Clinical narrative: tired; could've slept longer after the shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "cyst" (unspecified if ongoing), notes: he got a very small dose Cortisone shot behind his ear. The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "tired"; HYPERSOMNIA (non-serious), outcome "unknown", described as "could've slept longer after the shot".  Additional information: Caller mentioned he received the 1st dose of the Pfizer vaccine yesterday. He was held up by the nurse in the facility for 15-20 minutes because he mentioned to them that he got a very small dose Cortisone shot behind his ear from his dermatologist for a cyst 13 days ago. After debating, he finally got the shot. He mentioned that a day after his 2nd dose, he will go to his dentist for a bridge replacement and will be injected with Novocaine. He mentioned that originally, he will get a shot for his knee but is thinking of delaying for his shot. He would want to know if he can take the the Novocaine and proceed with the bridge replacement or how long should he wait before getting it.   No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: sore arm; a little bit of fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 63 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Covid-19 vaccine, for covid-19 immunisation. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm"; FATIGUE (non-serious), outcome "unknown", described as "a little bit of fatigue".  Additional information: Patient and his wife received the 2nd dose of the Pfizer-BioNTech Covid-19 Vaccine yesterday. Other than sore arm and a little bit of fatigue, they did not feel any other side effects Consumer wants to know if the vaccine would still work even if they did not experience any other side effects. Patient asked how they would know if the Pfizer-BioNTech Covid-19 Vaccine already worked on him and his wife.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 54.0
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: feeling light headed; vertigo sensation; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 54 year-old patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) for 1 day at the age of 54 years as dose 1,single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "feeling light headed"; VERTIGO (non-serious), outcome "unknown", described as "vertigo sensation".  Additional information: The patient got the first injection on Tuesday the 23rd and about a week later, when woke up and had a vertigo sensation and feeling light headed, patient had this the last 3 mornings. It gets better as the day goes on but the first three hours are bad. The patient wants to know is this a normal side effect of the vaccine?. The patient stated whether there is a need to take the second shot of vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Nerve compression
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. A 75 year-old male patient received bnt162b2 (BNT162B2), administration date 25Feb2021 (Batch/Lot number: unknown) at the age of 75 years as dose 1,single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NERVE COMPRESSION (non-serious), outcome "unknown", described as "pinched nerve". Additional Information: The patient  went to the doctor 2 days ago for a pinched nerve in his back and was given a prescription for prednisone. The patient told the doctor he had just had the vaccine a few days before. Caller sat on hold with the CDC hotline for two hours and was disconnected. The patient had read online no to take anti-inflammatory drugs, alcohol, or pain medications for 2 weeks after getting the vaccine because it could reduce the efficacy of the vaccine. Should he not take this prednisone?  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Feeling hot, Headache, Vomiting
Clinical narrative: headache; chills; dizziness; vomiting; hot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A female patient received bnt162b2 (BNT162B2), administration date 02Mar2021 (Lot number: ENG203, Expiration Date: 30Jun2021) as dose 1, single for covid-19 immunisation. Relevant medical history included: "covid", start date: Oct2020 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache"; CHILLS (non-serious), outcome "unknown", described as "chills"; DIZZINESS (non-serious), outcome "unknown", described as "dizziness"; VOMITING (non-serious), outcome "unknown", described as "vomiting"; FEELING HOT (non-serious), outcome "unknown", described as "hot". Additional information: The caller was calling about the Pfizer covid vaccine, the caller just had covid back in October, the 8th or something like that, it was a very mild case. The caller got the first dose of the vaccine this past Tuesday 02Mar2021. The problem was the caller got hit pretty hard with the first shot. It was not horrible, she had headache, chills, hot, no fever, she knows it's to be expected, she vomited a couple of times. The caller woke up dizzy then it went away. The caller heard that the people who have had covid were the ones who get hit with the hard punches, she was scared of the second shot because she heard it was worse than the first one. Does she have to get the second dose for immunization? The caller mentions she couldn't see anything anymore when looking at the vaccination card. Lot number captured as provided. No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Gastrooesophageal reflux disease, Headache, Influenza
Clinical narrative: headache; chills; dizziness; vomiting; hot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A female patient received bnt162b2 (BNT162B2), administration date 02Mar2021 (Lot number: ENG203, Expiration Date: 30Jun2021) as dose 1, single for covid-19 immunisation. Relevant medical history included: "covid", start date: Oct2020 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache"; CHILLS (non-serious), outcome "unknown", described as "chills"; DIZZINESS (non-serious), outcome "unknown", described as "dizziness"; VOMITING (non-serious), outcome "unknown", described as "vomiting"; FEELING HOT (non-serious), outcome "unknown", described as "hot". Additional information: The caller was calling about the Pfizer covid vaccine, the caller just had covid back in October, the 8th or something like that, it was a very mild case. The caller got the first dose of the vaccine this past Tuesday 02Mar2021. The problem was the caller got hit pretty hard with the first shot. It was not horrible, she had headache, chills, hot, no fever, she knows it's to be expected, she vomited a couple of times. The caller woke up dizzy then it went away. The caller heard that the people who have had covid were the ones who get hit with the hard punches, she was scared of the second shot because she heard it was worse than the first one. Does she have to get the second dose for immunization? The caller mentions she couldn't see anything anymore when looking at the vaccination card. Lot number captured as provided. No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sluggishness, Vaccination site pain, Vomiting
Clinical narrative: headache; chills; dizziness; vomiting; hot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A female patient received bnt162b2 (BNT162B2), administration date 02Mar2021 (Lot number: ENG203, Expiration Date: 30Jun2021) as dose 1, single for covid-19 immunisation. Relevant medical history included: "covid", start date: Oct2020 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache"; CHILLS (non-serious), outcome "unknown", described as "chills"; DIZZINESS (non-serious), outcome "unknown", described as "dizziness"; VOMITING (non-serious), outcome "unknown", described as "vomiting"; FEELING HOT (non-serious), outcome "unknown", described as "hot". Additional information: The caller was calling about the Pfizer covid vaccine, the caller just had covid back in October, the 8th or something like that, it was a very mild case. The caller got the first dose of the vaccine this past Tuesday 02Mar2021. The problem was the caller got hit pretty hard with the first shot. It was not horrible, she had headache, chills, hot, no fever, she knows it's to be expected, she vomited a couple of times. The caller woke up dizzy then it went away. The caller heard that the people who have had covid were the ones who get hit with the hard punches, she was scared of the second shot because she heard it was worse than the first one. Does she have to get the second dose for immunization? The caller mentions she couldn't see anything anymore when looking at the vaccination card. Lot number captured as provided. No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Visual impairment
Clinical narrative: being dizzy; side effects affecting eye sight, like your vision is going in and out like you seeing spots; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as single dose for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "being dizzy"; VISUAL IMPAIRMENT (non-serious), outcome "unknown", described as "side effects affecting eye sight, like your vision is going in and out like you seeing spots". No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Feeling cold, Feeling hot, Pain
Clinical narrative: body aches; chills; went to bed and felt extremely hot; was "drained of energy" for the next couple of days / has no energy; "couldn't get warm enough" and that he's "still cold"; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 62 year-old male patient received bnt162b2 (BNT162B2), administration date 22Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st Dose), for Covid-19 Immunisation. The following information was reported: PAIN (non-serious), outcome "recovered", described as "body aches"; CHILLS (non-serious), outcome "recovered", described as "chills"; ASTHENIA (non-serious) with onset 03Mar2021, outcome "unknown", described as "was "drained of energy" for the next couple of days / has no energy"; FEELING COLD (non-serious) with onset 03Mar2021, outcome "unknown", described as ""couldn't get warm enough" and that he's "still cold""; FEELING HOT (non-serious), outcome "unknown", described as "went to bed and felt extremely hot".  Additional Information: The patient experienced body aches and chills following both doses, duration after first dose was 2-3 days and second dose was 2 days before resolving. After the second dose body aches and chills resolved, he stated his was "drained of energy" for the next couple of days. He now reports that yesterday afternoon (03Mar2021) he "couldn't get warm enough" and that he's "still cold" and has no energy. He "went to bed and felt extremely hot" but didn't take his temperature. The patient wanted to know whether this is from the vaccine, or it was common for symptoms to recur. The patient also reported that he commonly has reactions to vaccination, siting that last year after he received his Shingles vaccines he "felt horrible after". The patient haven't been around anyone, no energy. Felt horrible after both doses of shingles. The patient wore two masks, excellent filter in my personal mask, stayed outside.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Paranasal sinus discomfort
Clinical narrative: sinus pressure; mild headache; fatigue; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021260053 (Pfizer).  A female patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Lot number: EN6198) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PARANASAL SINUS DISCOMFORT (non-serious), outcome "unknown", described as "sinus pressure"; HEADACHE (non-serious), outcome "unknown", described as "mild headache"; FATIGUE (non-serious), outcome "unknown", described as "fatigue".  Additional information: The patient Received first dose COVID vaccine on 03MAR2021.Just wants to know if a mild headache and sort of a sinus pressure is normal for a side effect. Caller stated her friends has stated to her that the second dose gives you more side effects than the initial dose.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased
Clinical narrative: temperature of "100 point something" / her normal temperature is always 97; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 76 year-old female patient received bnt162b2 (BNT162B2), administration date 01Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for COVID-19 IMMUNIZATION. The following information was reported: BODY TEMPERATURE INCREASED (non-serious) with onset 2021, outcome "recovered" (2021), described as "temperature of "100 point something" / her normal temperature is always 97". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Reported that after her second dose, she had a temperature of "100 point something" but it "wasn't a big deal" as she came home and went to bed, and reported that she was good the next morning. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 58 year-old female patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "rheumatoid arthritis" (unspecified if ongoing), notes: She has a couple of autoimmune disorders, rheumatoid arthritis and bilateral polyneuropathy, plus COPD. "bilateral polyneuropathy" (unspecified if ongoing), notes: She has a couple of autoimmune disorders, rheumatoid arthritis and bilateral polyneuropathy, plus COPD.; "COPD" (unspecified if ongoing), notes: She has a couple of autoimmune disorders, rheumatoid arthritis and bilateral polyneuropathy, plus COPD. "Guillain-Barre syndrome" (unspecified if ongoing), notes: She is concerned because her condition is very similar to Guillain-Barre syndrome.; "autoimmune disorders" (unspecified if ongoing), notes: She has a couple of autoimmune disorders, rheumatoid arthritis and bilateral polyneuropathy, plus COPD. The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "unknown", described as "sore arm". Additional information:The patient received the first dose of Pfizer's vaccine yesterday, they gave her a booklet and a fact sheet where she saw she should mention to the provider that she's immunocompromised. She has a couple of autoimmune disorders, rheumatoid arthritis and bilateral polyneuropathy, plus COPD. Is it okay that she got the vaccine. She is concerned because her condition is very similar to Guillain-Barre syndrome. After the vaccine she has only had a sore arm. But she is concerned something else might go on. She was wondering if she might need a third dose at some point. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Chills, Fatigue, Illness, Mobility decreased
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A female patient received bnt162b2 (BNT162B2), administration date 26Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "I was with the covid virus" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "very sick"; CHILLS (non-serious), outcome "unknown", described as "chills"; FATIGUE (non-serious), outcome "unknown", described as "fatigued"; PAIN (non-serious), outcome "unknown", described as "aches and pains"; MOBILITY DECREASED (non-serious), outcome "unknown", described as "couldn't put one foot in front of the other"; BEDRIDDEN (non-serious), outcome "unknown", described as "I was in bed for two days". Additional information: This AE was reported by caller's friend, earlier today and he left her phone number for a callback. Caller states that she got the Pfizer covid shot on 26Feb and for 5 days, she was very sick with chills, fatigued, couldn't put one foot in front of the other and had aches and pains out of this world. she was sicker after the shot than when she was with the covid virus. she was in bed for two days, and concerned about the 2nd shot. she didn't have any immediate reactions, at first and thought this isn't bad and tough. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A female patient received bnt162b2 (BNT162B2), administration date 26Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "I was with the covid virus" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "very sick"; CHILLS (non-serious), outcome "unknown", described as "chills"; FATIGUE (non-serious), outcome "unknown", described as "fatigued"; PAIN (non-serious), outcome "unknown", described as "aches and pains"; MOBILITY DECREASED (non-serious), outcome "unknown", described as "couldn't put one foot in front of the other"; BEDRIDDEN (non-serious), outcome "unknown", described as "I was in bed for two days". Additional information: This AE was reported by caller's friend, earlier today and he left her phone number for a callback. Caller states that she got the Pfizer covid shot on 26Feb and for 5 days, she was very sick with chills, fatigued, couldn't put one foot in front of the other and had aches and pains out of this world. she was sicker after the shot than when she was with the covid virus. she was in bed for two days, and concerned about the 2nd shot. she didn't have any immediate reactions, at first and thought this isn't bad and tough. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.